Coma in adult cerebral venous thrombosis: The BEAST study.

CVT cerebral venous thrombosis characteristics coma predictors women

Journal

European journal of neurology
ISSN: 1468-1331
Titre abrégé: Eur J Neurol
Pays: England
ID NLM: 9506311

Informations de publication

Date de publication:
22 Apr 2024
Historique:
revised: 04 04 2024
received: 05 02 2024
accepted: 06 04 2024
medline: 22 4 2024
pubmed: 22 4 2024
entrez: 22 4 2024
Statut: aheadofprint

Résumé

Coma is an independent predictor of poor clinical outcomes in cerebral venous thrombosis (CVT). We aimed to describe the association of age, sex, and radiological characteristics of adult coma patients with CVT. We used data from the international, multicentre prospective observational BEAST (Biorepository to Establish the Aetiology of Sinovenous Thrombosis) study. Only positively associated variables with coma with <10% missing data in univariate analysis were considered for the multivariate logistic regression model. Of the 596 adult patients with CVT (75.7% women), 53 (8.9%) patients suffered coma. Despite being a female-predominant disease, the prevalence of coma was higher among men than women (13.1% vs. 7.5%, p = 0.04). Transverse sinus thrombosis was least likely to be associated with coma (23.9% vs. 73.3%, p < 0.001). The prevalence of superior sagittal sinus thrombosis was higher among men than women in the coma sample (73.6% vs. 37.5%, p = 0.01). Men were significantly older than women, with a median (interquartile range) age of 51 (38.5-60) versus 40 (33-47) years in the coma (p = 0.04) and 44.5 (34-58) versus 37 (29-48) years in the non-coma sample (p < 0.001), respectively. Furthermore, an age- and superior sagittal sinus-adjusted multivariate logistic regression model found male sex (odds ratio = 1.8, 95% confidence interval [CI] = 1.0-3.4, p = 0.04) to be an independent predictor of coma in CVT, with an area under the receiver operating characteristic curve of 0.61 (95% CI = 0.52-0.68, p = 0.01). Although CVT is a female-predominant disease, men were older and nearly twice as likely to suffer from coma than women.

Sections du résumé

BACKGROUND AND PURPOSE OBJECTIVE
Coma is an independent predictor of poor clinical outcomes in cerebral venous thrombosis (CVT). We aimed to describe the association of age, sex, and radiological characteristics of adult coma patients with CVT.
METHODS METHODS
We used data from the international, multicentre prospective observational BEAST (Biorepository to Establish the Aetiology of Sinovenous Thrombosis) study. Only positively associated variables with coma with <10% missing data in univariate analysis were considered for the multivariate logistic regression model.
RESULTS RESULTS
Of the 596 adult patients with CVT (75.7% women), 53 (8.9%) patients suffered coma. Despite being a female-predominant disease, the prevalence of coma was higher among men than women (13.1% vs. 7.5%, p = 0.04). Transverse sinus thrombosis was least likely to be associated with coma (23.9% vs. 73.3%, p < 0.001). The prevalence of superior sagittal sinus thrombosis was higher among men than women in the coma sample (73.6% vs. 37.5%, p = 0.01). Men were significantly older than women, with a median (interquartile range) age of 51 (38.5-60) versus 40 (33-47) years in the coma (p = 0.04) and 44.5 (34-58) versus 37 (29-48) years in the non-coma sample (p < 0.001), respectively. Furthermore, an age- and superior sagittal sinus-adjusted multivariate logistic regression model found male sex (odds ratio = 1.8, 95% confidence interval [CI] = 1.0-3.4, p = 0.04) to be an independent predictor of coma in CVT, with an area under the receiver operating characteristic curve of 0.61 (95% CI = 0.52-0.68, p = 0.01).
CONCLUSIONS CONCLUSIONS
Although CVT is a female-predominant disease, men were older and nearly twice as likely to suffer from coma than women.

Identifiants

pubmed: 38646961
doi: 10.1111/ene.16311
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e16311

Subventions

Organisme : NIH HHS
Pays : United States

Informations de copyright

© 2024 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.

Références

Ferro JM, Bousser M‐G, Canhão P, et al. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis‐ endorsed by the European Academy of Neurology. Eur J Neurol. 2017;24:1203‐1213.
Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F, ISCVT Investigators. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004;35(3):664‐670.
Liang J, Chen H, Li Z, et al. Cortical vein thrombosis in adult patients of cerebral venous sinus thrombosis correlates with poor outcome and brain lesions: a retrospective study. BMC Neurol. 2017;17(1):219.
Debek A, Moukhalalati M. Coma from cerebral venous thrombosis: an overlooked cause. Emerg Med J. 2008;25(7):410.
Gupta S, Soni R, Dhull P, Somasekharan M, Sreen A. Glasgow coma scale ≤ 12 at admission is a predictor of poor functional outcome (mRS 2‐6) at one year in patients with cerebral venous thrombosis. J Stroke Cerebrovasc Dis. 2021;30(7):105811.
Kowoll CM, Kaminski J, Weiß V, et al. Severe cerebral venous and sinus thrombosis: clinical course, imaging correlates, and prognosis. Neurocrit Care. 2016;25(3):392‐399.
Chu X, Zhang J, Zhang B, Zhao Y. Analysis of age and prevention strategy on outcome after cerebral venous thrombosis. Biomed Res Int. 2020;2020:6637692.
Cotlarciuc I, Marjot T, Khan MS, et al. Towards the genetic basis of cerebral venous thrombosis‐the BEAST Consortium: a study protocol. BMJ Open. 2016;6:e012351.
Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974;2(7872):81‐84.
Arauz A, Barboza MA, Quintero LC, Cantu C, Chiquete E, Serrano F. Prognosis of patients with severe cerebral venous thrombosis treated with decompressive craniectomy. Neurologia. 2023;38:617‐624.
Simonin A, Rusca M, Saliou G, Levivier M, Daniel RT, Oddo M. Multimodal regional brain monitoring of tissue ischemia in severe cerebral venous sinus thrombosis. Neurocrit Care. 2019;31:297‐303.
Gariel F, Berge J, Dousset V. Neurological recovery after coma related to diffuse cerebral venous sinus thrombosis. Interest in thrombi‐aspiration with Penumbra system. Interv Neuroradiol. 2015;21(2):218‐221.
Ranjan R, Ken‐Dror G, Martinelli I, et al. Age of onset of cerebral venous thrombosis: the BEAST study. Eur Stroke J. 2023;8(1):344‐350.
Shapiro M, Raz E, Nossek E, et al. Cerebral venous anatomy: implications for the neurointerventionalist. J Neurointerv Surg. 2023;15(5):452‐460.
Ranjan R, Ken‐Dror G, Sharma P. Pathophysiology, diagnosis and management of cerebral venous thrombosis: a comprehensive review. Medicine. 2023;102(48):e36366.

Auteurs

Redoy Ranjan (R)

Institute of Cardiovascular Research Royal Holloway, University of London (ICR2UL), London, UK.

Gie Ken-Dror (G)

Institute of Cardiovascular Research Royal Holloway, University of London (ICR2UL), London, UK.

Ida Martinelli (I)

Fondazione IRCCS Ca'Granda-Ospedale Maggiore Policlinico, A. Bianchi Bonomi Hemophilia and Thrombosis Centre, Milan, Italy.
Moncucco Hospital Group, Moncucco Clinic, Hematology Service, Lugano, Switzerland.

Elvira Grandone (E)

Atherosclerosis and Thrombosis Unit, IRCCS Home for the Relief of Suffering, S. Giovanni Rotondo, Foggia, Italy.
Medical and Surgical Department, University of Foggia, Foggia, Italy.

Sini Hiltunen (S)

Department of Neurology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.

Erik Lindgren (E)

Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden.

Maurizio Margaglione (M)

Medical Genetics, Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy.

Veronique Le Cam Duchez (VLC)

University of Rouen Normandy, Inserm U1096, CHU Rouen, Vascular Hemostasis Unit and Inserm CIC-CRB 1404, Rouen, France.

Aude Triquenot Bagan (A)

Department of Neurology, CHU Rouen, Rouen, France.

Marialuisa Zedde (M)

Neurology Unit, Stroke Unit, Local Health Unit-Authority IRCCS of Reggio Emilia, Reggio Emilia, Italy.

Nicola Giannini (N)

Department of Clinical and Experimental Medicine, Neurological Institute, University of Pisa, Pisa, Italy.

Ynte M Ruigrok (YM)

UMC Utrecht Brain Centre, Department of Neurology and Neurosurgery, University Medical Centre Utrecht, Utrecht, the Netherlands.

Bradford B Worrall (BB)

Departments of Neurology and Public Health Sciences, University of Virginia, Charlottesville, Virginia, USA.

Jennifer J Majersik (JJ)

Department of Neurology, University of Utah, Salt Lake City, Utah, USA.

Jukka Putaala (J)

Department of Neurology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.

Elena Haapaniemi (E)

Department of Neurology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.

Susanna M Zuurbier (SM)

Department of Neurology, Amsterdam University Medical Centres, location AMC, Amsterdam Neuroscience, University of Amsterdam, Amsterdam, the Netherlands.

Matthijs C Brouwer (MC)

Department of Neurology, Amsterdam University Medical Centres, location AMC, Amsterdam Neuroscience, University of Amsterdam, Amsterdam, the Netherlands.

Serena M Passamonti (SM)

Fondazione IRCCS Ca'Granda-Ospedale Maggiore Policlinico, A. Bianchi Bonomi Hemophilia and Thrombosis Centre, Milan, Italy.

Maria Abbattista (M)

Fondazione IRCCS Ca'Granda-Ospedale Maggiore Policlinico, A. Bianchi Bonomi Hemophilia and Thrombosis Centre, Milan, Italy.

Paolo Bucciarelli (P)

Fondazione IRCCS Ca'Granda-Ospedale Maggiore Policlinico, A. Bianchi Bonomi Hemophilia and Thrombosis Centre, Milan, Italy.

Robin Lemmens (R)

Department of Neurosciences, Experimental Neurology, KU Leuven-University of Leuven, Leuven, Belgium.
VIB Centre for Brain & Disease Research, Leuven, Belgium.
Department of Neurology, University Hospitals Leuven, Leuven, Belgium.

Emanuela Pappalardo (E)

Fondazione IRCCS Ca'Granda-Ospedale Maggiore Policlinico, A. Bianchi Bonomi Hemophilia and Thrombosis Centre, Milan, Italy.
Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.

Paolo Costa (P)

Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.

Marina Colombi (M)

Division of Biology and Genetics, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.

Diana Aguiar de Sousa (D)

Stroke Centre, Lisbon Central University Hospital, Lisbon, Portugal.
CEEM and Institute of Anatomy, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.

Sofia Rodrigues (S)

Centro de Estudos Egas Moniz, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal.
Department of Neurosciences, Hospital of Santa Maria, University of Lisbon, Lisbon, Portugal.

Patrícia Canhão (P)

Centro de Estudos Egas Moniz, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal.
Department of Neurosciences, Hospital of Santa Maria, University of Lisbon, Lisbon, Portugal.

Aleksander Tkach (A)

Interior Health, Kelowna, British Columbia, Canada.

Rosa Santacroce (R)

Medical Genetics, Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy.

Giovanni Favuzzi (G)

Atherosclerosis and Thrombosis Unit, IRCCS Home for the Relief of Suffering, S. Giovanni Rotondo, Foggia, Italy.

Antonio Arauz (A)

Stroke Clinic, National Institute of Neurology and Neurosurgery Manuel Velasco Suarez, Mexico City, Mexico.

Donatella Colaizzo (D)

Atherosclerosis and Thrombosis Unit, IRCCS Home for the Relief of Suffering, S. Giovanni Rotondo, Foggia, Italy.

Kostas Spengos (K)

Department of Neurology, Eginition Hospital, University of Athens School of Medicine, Athens, Greece.

Amanda Hodge (A)

Pathology and Molecular Medicine, Population Health Research Institute and Thrombosis and Atherosclerosis Research Institute, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada.

Reina Ditta (R)

Pathology and Molecular Medicine, Population Health Research Institute and Thrombosis and Atherosclerosis Research Institute, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada.

Alessandro Pezzini (A)

Department of Medicine and Surgery, University of Parma, Parma, Italy.
Stroke Program, Department of Emergencies, Parma University Hospital, Parma, Italy.

Jonathan M Coutinho (JM)

Department of Neurosciences, Experimental Neurology, KU Leuven-University of Leuven, Leuven, Belgium.
VIB Centre for Brain & Disease Research, Leuven, Belgium.
Department of Neurology, University Hospitals Leuven, Leuven, Belgium.

Vincent Thijs (V)

Stroke Division, Florey Institute of Neuroscience and Mental Health, University of Melbourne, Heidelberg, Victoria, Australia.

Katarina Jood (K)

Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden.

Turgut Tatlisumak (T)

Department of Neurology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden.

José M Ferro (JM)

Instituto de Medicina Molecular João Lobo Antunes, Universidade de Lisboa, Lisboa, Portugal.

Pankaj Sharma (P)

Institute of Cardiovascular Research Royal Holloway, University of London (ICR2UL), London, UK.
Department of Clinical Neuroscience, Imperial College Healthcare NHS Trust, London, UK.

Classifications MeSH